Marc Cluzel - Member & Supervisory Board @ MorphoSys

Overview

Number of Founded Organizations

CB Rank (Person)

Professional Development

Since 2011 Founder and Consultant for C&F Consulting, Paris, France

Since 2011 Executive Vice President of Product Development at HÙYÀ Bioscience International, LLC

2009 - 2010 Executive Vice President of Research & Development of Sanofi, Paris France

2007 – 2009 Senior Vice President of Science and Medical

Affairs of Sanofi, Paris, France

2002 – 2011 Chairman and Chief Executive Officer of Sanofi-Aventis R&D France, Paris, France

1996 – 2001 Head of Project Direction of Sanofi R&D

1993 – 1996 Project Director Sanofi R&D.

Education

1983 - 1990 Ph.D. Biochemistry at University of Montpellier, France

1973 - 1985 Study of Medicine at University of Montpellier, France

Membership in other Supervisory Boards and other current mandates

Currently no other mandates.

Dr. Cluzel is a member of MorphoSys AG's Supervisory Board since 2012."

Number of Current Jobs

Number of Past Jobs

is the

Member & Supervisory Board

. Additionally,

has had

past jobs including

Chairman and Chief Executive Officer

Organization Name	Title At Company	Start Date	End Date
Sanofi	Chairman and Chief Executive Officer	2002	2011
Sanofi	Executive Vice President of Research & Development	2009	2010
Sanofi	Senior Vice President of Science and Medical Affairs	2007	2009
Sanofi	Head of Project Direction	1996	2001
Sanofi	Project Director	1993	1996
HUYA Bioscience	Executive Vice President of Product Development	2011	—
C&F Consulting	Founder and Consultant	2011	—

Hub Name	CB Rank (Hub)
Health Diagnostics Companies that Exited	16,942
University of Zurich Alumni Founded Companies	97,123
University of British Columbia Alumni Founded Companies	98,806
Harvard University Alumni Founded Companies	81,189
Harvard Medical School Alumni Founded Companies	75,653
Closed Medical Companies	14,432
Closed Biotechnology Companies	7,790
Closed Health Diagnostics Companies	38,379
Closed Health Care Companies (Top 10K)	5,661
Acquired Health Diagnostics Companies	18,020